These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 37150326)

  • 1. Lipid nanoparticle-mediated drug delivery to the brain.
    Khare P; Edgecomb SX; Hamadani CM; Tanner EEL; S Manickam D
    Adv Drug Deliv Rev; 2023 Jun; 197():114861. PubMed ID: 37150326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
    Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
    AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of lipid components in lipid nanoparticles for vaccines and gene therapy.
    Hald Albertsen C; Kulkarni JA; Witzigmann D; Lind M; Petersson K; Simonsen JB
    Adv Drug Deliv Rev; 2022 Sep; 188():114416. PubMed ID: 35787388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs.
    Suzuki Y; Ishihara H
    Drug Metab Pharmacokinet; 2021 Dec; 41():100424. PubMed ID: 34757287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
    Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
    Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
    Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
    ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood-Brain Barrier Transfection and Crossing.
    Han EL; Padilla MS; Palanki R; Kim D; Mrksich K; Li JJ; Tang S; Yoon IC; Mitchell MJ
    Nano Lett; 2024 Feb; 24(5):1477-1486. PubMed ID: 38259198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs.
    Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K
    J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
    Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
    AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications.
    Jeong M; Lee Y; Park J; Jung H; Lee H
    Adv Drug Deliv Rev; 2023 Sep; 200():114990. PubMed ID: 37423563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Nanoparticle (LNP) Chemistry Can Endow Unique
    Johnson LT; Zhang D; Zhou K; Lee SM; Liu S; Dilliard SA; Farbiak L; Chatterjee S; Lin YH; Siegwart DJ
    Mol Pharm; 2022 Nov; 19(11):3973-3986. PubMed ID: 36154076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery.
    Maeki M; Uno S; Niwa A; Okada Y; Tokeshi M
    J Control Release; 2022 Apr; 344():80-96. PubMed ID: 35183654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Lipid Nanoparticles for the Delivery of Macromolecules Based on the Molecular Design of pH-Sensitive Cationic Lipids.
    Sato Y
    Chem Pharm Bull (Tokyo); 2021; 69(12):1141-1159. PubMed ID: 34853281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
    Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
    Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
    Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery Strategies for mRNA Vaccines.
    Ramachandran S; Satapathy SR; Dutta T
    Pharmaceut Med; 2022 Feb; 36(1):11-20. PubMed ID: 35094366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Efficacy and Mechanism Driven Study on the Impact of Hypoxia on Lipid Nanoparticle Mediated mRNA Delivery.
    Ma Y; Fenton OS
    J Am Chem Soc; 2023 May; 145(20):11375-11386. PubMed ID: 37184377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.